000 | 01716 a2200505 4500 | ||
---|---|---|---|
005 | 20250515074501.0 | ||
264 | 0 | _c20080108 | |
008 | 200801s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.01590-06 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMartins, H R | |
245 | 0 | 0 |
_aImpact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cSep 2007 |
||
300 |
_a3282-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChagas Disease _xdrug therapy |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMicrosatellite Repeats |
650 | 0 | 4 |
_aNitroimidazoles _xtherapeutic use |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aTrypanocidal Agents _xtherapeutic use |
650 | 0 | 4 |
_aTrypanosoma cruzi _xgenetics |
700 | 1 | _aSilva, R Moreira | |
700 | 1 | _aValadares, H M S | |
700 | 1 | _aToledo, M J O | |
700 | 1 | _aVeloso, V M | |
700 | 1 | _aVitelli-Avelar, D M | |
700 | 1 | _aCarneiro, C M | |
700 | 1 | _aMachado-Coelho, G L L | |
700 | 1 | _aBahia, M T | |
700 | 1 | _aMartins-Filho, O A | |
700 | 1 | _aMacedo, A M | |
700 | 1 | _aLana, M | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 51 _gno. 9 _gp. 3282-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.01590-06 _zAvailable from publisher's website |
999 |
_c17173041 _d17173041 |